Ann Arbor-based Unitech Pharmaceuticals, Inc. landed its 15th patent related to cancer treatment.
Excerpt:
The major advantage of Unitech's patented
platinum compounds is that they have much greater selectivity in attacking only
cancer cells, reducing the side effects of chemotherapy. The conversion through
a "biotrigger" between active and inactive states of the compounds is even
reversible.
Read entire blurb here (scroll down).
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.